Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06160427 · ClinicalTrials.gov registry record · Phase 4
Connective Tissue Matrix for Rotator Cuff Tendinopathy
A Phase 4 study of Shoulder Pain and Tendinopathy, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- Active
- Registry status
- Phase 4
- Development phase
- 92
- Enrollment target
- 4
- Study locations
NCT06160427: Active Phase 4 study of Shoulder Pain and Tendinopathy, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
NCT06160427 is a Phase 4 study of Shoulder Pain and Tendinopathy that is active but no longer recruiting, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 92 participants, roughly in line with the 98-participant average among 27 other Shoulder Pain trials with a reported enrollment target. The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06160427, a Phase 4 study of Shoulder Pain and Tendinopathy, is active but no longer recruiting, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 92 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this research study is to determine if the effectiveness of a single injection of CTM Boost in the treatment of patients with rotator cuff tendinopathy (RCT) is as effective as a single injection of platelet rich plasma (PRP) in reducing the symptoms of RCT.
Primary Outcome
Mean Western Ontario Rotator Cuff Index (WORC) Score The WORC has 21 items in four domains, including physical symptoms (10 questions), sports/recreation/work (4 questions), lifestyle (4 questions) and emotions (3 questions). Raw scores range from 0 to 2100, with a higher score indicating decreased quality of life because of pathological condition of the rotator cuff.
Conditions Studied
Interventions
- BIOLOGICAL CTM Boost
- BIOLOGICAL PRP
Study Locations (4)
Pennsylvania
- Allegheny Health Network Allegheny General Hospital - Pittsburgh
- Allegheny Health Network Federal North Medical Office Building - Pittsburgh
- AHN Wexford Health & Wellness Pavilion - Wexford
- AHN Wexford Hospital - Wexford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2023-12-04 |
| Est. Completion | 2028-01-15 |
| Phase | Phase 4 |
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)34 total trials
What the registry record for NCT06160427 still lists
NCT06160427 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, roughly in line with the 98-participant average among 27 other Shoulder Pain trials with a reported enrollment target.
The record links to 4 conditions, with Shoulder Pain appearing as the primary indexed condition, and to 2 interventions - of which CTM Boost is the first listed.
NCT06160427 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06160427 about?
NCT06160427 is a clinical study titled "Connective Tissue Matrix for Rotator Cuff Tendinopathy". The purpose of this research study is to determine if the effectiveness of a single injection of CTM Boost in the treatment of patients with rotator cuff tendinopathy (RCT) is as effective as a single injection of platelet rich plasma (PRP) in reducing the symptoms of RCT.
What is the current status of trial NCT06160427?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 92 participants. The study started on 2023-12-04. Estimated completion is 2028-01-15.
What conditions does trial NCT06160427 study?
This clinical trial studies the following conditions: Shoulder Pain, Tendinopathy, Rotator Cuff Tendinitis, Rotator Cuff Tendinosis.
What interventions are being tested in trial NCT06160427?
The interventions under investigation include: CTM Boost (BIOLOGICAL), PRP (BIOLOGICAL).
Who is sponsoring clinical trial NCT06160427?
This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06160427 being conducted?
This trial has 4 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shoulder Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06160427's enrollment target sits among peer trials
92 9th of 27 higher than 18 of 27 other Shoulder Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Shoulder Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Opioid-Free Pain Protocol After Shoulder Arthroplasty
ACTIVE NOT RECRUITING · Phase 4
-
Liposomal Bupivacaine vs Dexamethasone ISB
COMPLETED · Phase 4
-
Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve Blockade for Arthroscopic Rotator Cuff Repair
COMPLETED · Phase 4
-
Shoulder RFA Pilot Study
RECRUITING
-
MDR - Comprehensive Primary Revision Stems PMCF
RECRUITING
-
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI